TrialClinical drug investigation2024

Radiomic Parameters for the Evaluation of Response to Treatment in Metastatic Colorectal Cancer Patients with Liver Metastasis: Findings from the CAVE-GOIM mCRC Phase 2 Trial.

Erika Martinelli et al.PubMed ↗Publisher ↗

No numbers read from the abstract.